May 02, 2020
Venus Medtech and Opus Medical Therapies, LLC Announce Partnership for Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) in Greater China Market
Mar 05, 2020
Cardiac Dimensions Hires Gretchen Gary As Vice President Of Global Therapy Development
Jan 30, 2020
Abbott's Tendyne(TM) Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Jan 13, 2020
Cardisio Demonstrates Unprecedented Accuracy in New Non-Invasive Coronary Artery Disease Detection
Jan 13, 2020
First Japanese Patients Randomized In Corvia Medical's REDUCE LAP-HF II Global Clinical Trial For Heart Failure
Jan 09, 2020
FAST BioMedical Announces Successful Completion of Multi-center Acute Congestive Heart Failure Trial in Germany
Dec 13, 2019
Clinical Data from Reprieve Cardiovascular's Successful First-in-Human Therapy for Acute Heart Failure Presented
Nov 17, 2019
Novartis PARAGON-HF analyses suggest Entresto® benefit beyond HFrEF
Nov 12, 2019
Boehringer Ingelheim and Lilly initiate first ever study to assess Jardiance® in people hospitalized for acute heart failure who have been stabilized
Oct 08, 2019
BioVentrix Enrolls and Treats First Patient in REVIVE-HF European RCT for Ischemic Heart Failure Patients
Sep 23, 2019
BioVentrix Announces Study Design for REVIVE-HF: Randomized Controlled Trial (RCT) in Europe
Sep 12, 2019
REDUCE FMR Study Shows Cardiac Dimensions' Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure
Sep 03, 2019
US Coronary Artery Disease Market and Competitive Landscape Report 2019
Sep 03, 2019
The European Society of Cardiology Includes Neovasc Reducer(TM) for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes
Sep 02, 2019
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings
Aug 16, 2019
CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Device
Aug 15, 2019
preCARDIA Enrolls First Patient in Early Feasibility Study
Jul 29, 2019
Magenta Medical Closes Funding Round Led by NEA in Its First-Ever Life Sciences Investment in Israel
Jul 22, 2019
Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study
Jun 27, 2019
Global Acute Decompensated Heart Failure (ADHF) Markets 2019: Disease Background, Treatment, Epidemiology, Marketed Drugs, Pipleine, Deals, Revenues & Landscape